A validation study of the Intentional Nonadherence Scale among people with type 2 diabetes in the United Kingdom.

Diabet Med · 2025 · PMC12080987 · PMID 40186412

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

‘Testing Treatment’ showed a trend towards statistical significance with adherence in 3–6 months (coefficient = −0.34, p = 0.09).

also in 53,322 other papers

borderline significantno p-value reported

Quantifying ‘Testing treatment’ through the INAS may enable clinicians to tailor their approach by balancing medical guidance with PwT2D's autonomy and providing early intervention, considering its borderline significant association with adherence in 3–6 months.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.